CMV
Clinical trials for CMV explained in plain language.
Never miss a new study
Get alerted when new CMV trials appear
Sign up with your email to follow new studies for CMV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Family donor immune cells take on post-transplant viruses in groundbreaking trial
Disease control Not yet recruitingThis study is for children and young adults who have a stubborn adenovirus or CMV infection after a stem cell transplant. It tests whether adding specially grown immune cells from a family donor to standard care can clear the virus better than standard care alone. About 69 partic…
Matched conditions: CMV
Phase: PHASE3 • Sponsor: New York Medical College • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug may offer easier protection against virus for kidney transplant patients
Prevention Not yet recruitingThis study compares two medications, letermovir and valganciclovir, to see which better prevents CMV infection in 300 kidney transplant recipients who carry the virus. Participants take the drug for 90 days after transplant, and researchers track infections for 12 months. The goa…
Matched conditions: CMV
Phase: PHASE4 • Sponsor: Elisabeth Kincaide • Aim: Prevention
Last updated May 19, 2026 11:47 UTC
-
New study seeks better ways to track hidden virus in transplant patients
Knowledge-focused Not yet recruitingThis study looks at 290 adults who have had a stem cell transplant and are taking letermovir to prevent CMV infection. Researchers want to see if measuring CMV-RNA and TTV-DNA in the blood can give a more accurate picture of active virus than the standard CMV-DNA test. The goal i…
Matched conditions: CMV
Sponsor: University of Rome Tor Vergata • Aim: Knowledge-focused
Last updated May 26, 2026 04:09 UTC
-
New blood test aims to stop viruses after kidney transplants
Knowledge-focused Not yet recruitingThis study will follow 1000 kidney transplant patients for 12 months to see if a new blood test called T-ID can predict and prevent two serious viral infections: CMV disease and BK virus kidney damage. The test measures virus levels and the body's immune strength. The goal is to …
Matched conditions: CMV
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC